| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/24/2023 | 148.62% | Keybanc | $20 → $18 | Maintains | Overweight |
| 10/04/2023 | 51.93% | Citigroup | $14 → $11 | Maintains | Neutral |
| 08/04/2023 | 51.93% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 08/03/2023 | 190.06% | Truist Securities | $20 → $21 | Maintains | Buy |
| 08/03/2023 | 120.99% | Oppenheimer | $17 → $16 | Maintains | Outperform |
| 08/03/2023 | 176.24% | Keybanc | $22 → $20 | Maintains | Overweight |
| 05/03/2023 | 176.24% | Truist Securities | $27 → $20 | Maintains | Buy |
| 05/03/2023 | 93.37% | Citigroup | $15 → $14 | Downgrades | Buy → Neutral |
| 05/03/2023 | 65.75% | Morgan Stanley | $13 → $12 | Maintains | Equal-Weight |
| 05/03/2023 | 148.62% | Barclays | $21 → $18 | Maintains | Overweight |
| 05/03/2023 | 203.87% | Keybanc | $25 → $22 | Maintains | Overweight |
| 04/13/2023 | 79.56% | Morgan Stanley | $14 → $13 | Maintains | Equal-Weight |
| 03/02/2023 | 245.3% | Keybanc | $18 → $25 | Maintains | Overweight |
| 02/15/2023 | 93.37% | Morgan Stanley | $11 → $14 | Maintains | Equal-Weight |
| 02/15/2023 | 190.06% | Barclays | $16 → $21 | Maintains | Overweight |
| 02/15/2023 | 148.62% | Keybanc | $16 → $18 | Maintains | Overweight |
| 12/06/2022 | 51.93% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 11/03/2022 | 65.75% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight |
| 11/03/2022 | 120.99% | Keybanc | $14 → $16 | Maintains | Overweight |
| 11/01/2022 | 93.37% | Keybanc | $15 → $14 | Maintains | Overweight |
| 08/04/2022 | 107.18% | Keybanc | $27 → $15 | Maintains | Overweight |
| 05/02/2022 | 272.93% | Keybanc | $30 → $27 | Maintains | Overweight |
| 03/15/2022 | 107.18% | Citigroup | $30 → $15 | Maintains | Buy |
| 02/28/2022 | 86.46% | Morgan Stanley | $17 → $13.5 | Maintains | Equal-Weight |
| 02/25/2022 | 134.81% | Oppenheimer | $30 → $17 | Maintains | Outperform |
| 02/25/2022 | 314.36% | Keybanc | $35 → $30 | Maintains | Overweight |
| 11/29/2021 | 314.36% | Oppenheimer | → $30 | Initiates Coverage On | → Outperform |
| 11/29/2021 | 231.49% | Morgan Stanley | → $24 | Initiates Coverage On | → Equal-Weight |
| 11/29/2021 | 314.36% | Citigroup | → $30 | Initiates Coverage On | → Buy |
| 11/29/2021 | 314.36% | Truist Securities | → $30 | Initiates Coverage On | → Buy |
| 11/29/2021 | 452.49% | B of A Securities | → $40 | Initiates Coverage On | → Buy |
| 11/29/2021 | 300.55% | Barclays | → $29 | Initiates Coverage On | → Overweight |
| 11/29/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 11/29/2021 | 383.43% | Keybanc | → $35 | Initiates Coverage On | → Overweight |
What is the target price for Nerdwallet (NRDS)?
The latest price target for Nerdwallet (NASDAQ: NRDS) was reported by Keybanc on October 24, 2023. The analyst firm set a price target for $18.00 expecting NRDS to rise to within 12 months (a possible 148.62% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nerdwallet (NRDS)?
The latest analyst rating for Nerdwallet (NASDAQ: NRDS) was provided by Keybanc, and Nerdwallet maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Nerdwallet (NRDS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nerdwallet, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nerdwallet was filed on October 24, 2023 so you should expect the next rating to be made available sometime around October 24, 2024.
Is the Analyst Rating Nerdwallet (NRDS) correct?
While ratings are subjective and will change, the latest Nerdwallet (NRDS) rating was a maintained with a price target of $20.00 to $18.00. The current price Nerdwallet (NRDS) is trading at is $7.24, which is out of the analyst's predicted range.